Dr. Margaret Hamburg, Commissioner of the FDA, stated at the RAPS 2009 Conference, “Just as biomedical research has evolved in the past decades, regulatory science — the science and tools we use to assess and evaluate product safety, efficacy, potency, quality and performance — must also evolve.”
Janet Woodcock, Director of Center for Drug Evaluation and Research - Guest Commissioner's Comments, August 17, 2007, "In all cases, we look to FDA reviewers and scientists to identify the most pressing problems and scientific issues, so that we can recruit partners to help us address them."
|